Day One Biopharmaceuticals (DAWN) Shares Outstanding: 2022-2025
Historic Shares Outstanding for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Sep 2025 value amounting to $102.7 million.
- Day One Biopharmaceuticals' Shares Outstanding rose 1.85% to $102.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $102.7 million, marking a year-over-year increase of 1.85%. This contributed to the annual value of $101.1 million for FY2024, which is 15.92% up from last year.
- Per Day One Biopharmaceuticals' latest filing, its Shares Outstanding stood at $102.7 million for Q3 2025, which was up 0.24% from $102.4 million recorded in Q2 2025.
- Day One Biopharmaceuticals' Shares Outstanding's 5-year high stood at $102.7 million during Q3 2025, with a 5-year trough of $61.9 million in Q1 2022.
- In the last 3 years, Day One Biopharmaceuticals' Shares Outstanding had a median value of $87.7 million in 2024 and averaged $92.6 million.
- Data for Day One Biopharmaceuticals' Shares Outstanding shows a peak YoY climbed of 18.83% (in 2023) over the last 5 years.
- Quarterly analysis of 4 years shows Day One Biopharmaceuticals' Shares Outstanding stood at $73.5 million in 2022, then climbed by 18.74% to $87.2 million in 2023, then climbed by 15.92% to $101.1 million in 2024, then rose by 1.85% to $102.7 million in 2025.
- Its Shares Outstanding was $102.7 million in Q3 2025, compared to $102.4 million in Q2 2025 and $101.4 million in Q1 2025.